Le Lézard
Classified in: Health, Sports and recreation
Subject: OFR

GNC Announces Proposed Senior Secured Notes Offering


PITTSBURGH, Nov. 8, 2017 /PRNewswire/ -- GNC Holdings, Inc. (NYSE: GNC) (the "Company"), a leading global specialty health, wellness and performance retailer, today announced that its wholly-owned subsidiary, General Nutrition Centers, Inc. (the "Issuer") intends to offer, subject to market conditions and other considerations, senior secured notes due 2022 (the "Notes") in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to non-U.S. persons outside the United States pursuant to Regulation S under the Securities Act. The Notes will be guaranteed on a senior secured basis by the Issuer's parent company, GNC Corporation, and by certain of the Issuer's direct and indirect subsidiaries that are borrowers or guarantors under a new senior secured term loan facility and new senior secured asset-based revolving credit facility.

GNC Logo.  (PRNewsFoto/GNC Holdings, Inc.)

The Company intends to use the net proceeds from this offering, together with borrowings under a new senior secured term loan facility and new senior secured asset-based revolving credit facility, to prepay and terminate its existing credit facility and to pay related fees and expenses. Any remaining net proceeds will be used for general corporate purposes.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale of these securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful.  The Notes will not be registered under the Securities Act or any state securities laws, and unless so registered, may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act and applicable state laws.  This notice is being issued pursuant to and in accordance with Rule 135c under the Securities Act.

About Us

GNC Holdings, Inc. (NYSE: GNC) ? headquartered in Pittsburgh, PA ? is a leading global specialty health, wellness and performance retailer.

GNC connects customers to their best selves by offering a premium assortment of heath, wellness and performance products, including protein, performance supplements, weight management supplements, vitamins, herbs and greens, wellness supplements, health and beauty, food and drink and other general merchandise. This assortment features proprietary GNC and nationally recognized third-party brands.

GNC's diversified, multi?channel business model generates revenue from product sales through company?owned retail stores, domestic and international franchise activities, third-party contract manufacturing, e?commerce and corporate partnerships.  As of September 30, 2017, GNC had approximately 9,000 locations, of which approximately 6,800 retail locations are in the United States (including approximately 2,400 Rite Aid franchise store?within?a?store locations) and franchise operations in approximately 50 countries.

Forward?Looking Statements Involving Known and Unknown Risks and Uncertainties

This release contains certain forward?looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to the Company's financial condition, results of operations and business that is not historical information.  Forward?looking statements can be identified by the use of terminology such as "subject to," "believes," "anticipates," "plans," "expects," "intends," "estimates," "projects," "may," "will," "should," "can," the negatives thereof, variations thereon and similar expressions, or by discussions regarding dividend, share repurchase plan, strategy and outlook.  While GNC believes there is a reasonable basis for its expectations and beliefs, they are inherently uncertain.  The Company may not realize its expectations and its beliefs may not prove correct.  Many factors could affect future performance and cause actual results to differ materially from those matters expressed in or implied by forward?looking statements, including but not limited to unfavorable publicity or consumer perception of the Company's products; costs of compliance and any failure on management's part to comply with new and existing governmental regulations governing our products; limitations of or disruptions in the manufacturing system or losses of manufacturing certifications; disruptions in the distribution network; or failure to successfully execute the Company's growth strategy, including any inability to expand franchise operations or attract new franchisees, any inability to expand company?owned retail operations, any inability to grow the international footprint, any inability to expand the e?commerce businesses, or any inability to successfully integrate businesses that are acquired.  The Company undertakes no obligation to publicly update or revise any forward?looking statement, whether as a result of new information, future events or otherwise.  Actual results could differ materially from those described or implied by such forward?looking statements.  For a listing of factors that may materially affect such forward?looking statements, please refer to the Company's Annual Report on Form 10?K for the year ended December 31, 2016.

Contacts:




Investors:

Tricia Tolivar, Executive Vice President & Chief Financial Officer,
(412) 288-2029




Amy N. Davis, Vice President Corporate Controller and Treasurer,
(412) 288-4641




Matt Milanovich, Senior Director ? Investor Relations, Analysis & Strategy,
(412) 402-7260  

 

SOURCE GNC Holdings, Inc.


These press releases may also interest you

at 11:34
At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided: Resolution in accordance with the Board's proposed dividend of SEK 1.00 per share for the financial year 2023. 29 April, 2024 was adopted as the...

at 11:25
TimelyCare, higher education's most trusted virtual health and well-being provider, has earned recognition as one of the World's Best Digital Health Companies by Newsweek, and has been awarded five Top Workplaces Awards for culture excellence....

at 11:16
Avanos Medical, Inc. will webcast its conference call discussing financial results and business highlights for the first quarter 2024 on Thursday, May 2 at 9 a.m., ET. The company will issue a news release detailing its results before the market...

at 11:15
Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision oncology therapeutics, announced the approval to expand the use of vebreltinib (also referred...

at 11:10
Through its 2030 Strategic Plan, NJII plans to double the size of the organization and to exceed $70M revenue as it rolls out various new initiatives focused on accelerating technology translation, spurring innovation and upskilling workers. As...

at 11:09
ScreenPoint Medical, today announced a significant transition in its leadership as Mark Koeniguer, the current CEO, steps down from his position. Mark served as CEO since 2022 and was instrumental in ScreenPoint's commercial growth and success over...



News published on and distributed by: